Literature DB >> 17160664

[Regional therapy of liver tumors].

H C Spangenberg1, L Mohr, H E Blum.   

Abstract

Malignant liver tumors are either originating from the liver, such as the primary liver tumors hepatocellular carcinoma and the cholangiocellular carcinoma, or metastases from extrahepatic malignancies. Apart from surgical procedures (resection, liver transplantation) percutaneous local-ablative (ethanol injection, radiofrequency thermal ablation as well as radiation therapy) and transarterial interventions are non-surgical therapeutic options. While these regional therapies have been shown in randomised controlled studies to be effective for hepatocellular carcinoma, their therapeutic efficacy in cholangiocellular carcinoma and liver metastases has not been shown. In the following we will summarize the regional therapeutic options in primary and secondary liver tumors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17160664     DOI: 10.1007/s00108-006-1771-z

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  42 in total

1.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

Review 2.  External beam radiation therapy for hepatocellular carcinoma: potential of intensity-modulated and image-guided radiation therapy.

Authors:  Martin Fuss; Bill J Salter; Terence S Herman; Charles R Thomas
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

3.  A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

Authors:  Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Shinpei Sato; Ryosuke Tateishi; Tomonori Fujishima; Takashi Ishikawa; Yukihiro Koike; Haruhiko Yoshida; Takao Kawabe; Masao Omata
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

4.  Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma.

Authors:  Gerd Otto; Sascha Herber; Michael Heise; Ansgar W Lohse; Christian Mönch; Fernando Bittinger; Maria Hoppe-Lotichius; Marcus Schuchmann; Anja Victor; Michael Pitton
Journal:  Liver Transpl       Date:  2006-08       Impact factor: 5.799

5.  Evaluation of combined therapy with chemoembolization and ethanol injection for advanced hepatocellular carcinoma.

Authors:  K Yamamoto; M Masuzawa; M Kato; K Kurosawa; A Kaneko; H Ishida; E Imamura; N J Park; Y Shirai; K Fujimoto; T Michida; N Hayashi; M Ikeda
Journal:  Semin Oncol       Date:  1997-04       Impact factor: 4.929

6.  Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study.

Authors:  Guan-Tarn Huang; Po-Huang Lee; Yuk-Ming Tsang; Ming-Yang Lai; Pei-Ming Yang; Rey-Heng Hu; Pei-Jer Chen; Jia-Horng Kao; Jin-Chuan Sheu; Cha-Ze Lee; Ding-Shinn Chen
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

7.  A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.

Authors:  Francis Y Yao; Ryutaro Hirose; Jeanne M LaBerge; Timothy J Davern; Nathan M Bass; Robert K Kerlan; Raphael Merriman; Sandy Feng; Chris E Freise; Nancy L Ascher; John P Roberts
Journal:  Liver Transpl       Date:  2005-12       Impact factor: 5.799

8.  Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.

Authors:  Shi-Ming Lin; Chun-Jung Lin; Chen-Chun Lin; Chao-Wei Hsu; Yi-Cheng Chen
Journal:  Gastroenterology       Date:  2004-12       Impact factor: 22.682

9.  Radiofrequency ablation of colorectal liver metastases.

Authors:  A R Gillams; W R Lees
Journal:  Abdom Imaging       Date:  2005 Jul-Aug

10.  Percutaneous radiofrequency ablation of colorectal hepatic metastases - initial experience. An adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastases.

Authors:  T J White; S H Roy-Choudhury; D J Breen; J Cast; A Maraveyas; E F Smyth; J E Hartley; J R T Monson
Journal:  Dig Surg       Date:  2004-09-13       Impact factor: 2.588

View more
  2 in total

1.  [Differentiated therapy of liver tumors].

Authors:  B Boozari; S Kubicka
Journal:  Internist (Berl)       Date:  2010-01       Impact factor: 0.743

2.  Trans-arterial chemoperfusion for the treatment of liver metastases of breast cancer and colorectal cancer: Clinical results in palliative care patients.

Authors:  Tatjana Gruber-Rouh; Marcel Langenbach; Nagy N N Naguib; Nour-Eldin M Nour-Eldin; Thomas J Vogl; Stephan Zangos; Martin Beeres
Journal:  World J Clin Oncol       Date:  2017-08-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.